“Experience in switching monoclonal antibodies in a patient with severe refractory atopic dermatitis: from Dupilumab to Abrocitinib. Case report ” (2025) Revista Alergia México, 72(4), pp. 382–385. doi:10.29262/ram.v72i4.1547.